Recruiting A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Medium to High Risk Myelofibrosis NCT07443306 Conditions MF Locations West China Hospital Sichuan University — Chengdu, Sichuan, China Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) — Tianjin, Tianjin Municipality, China View Trial Details
Recruiting A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis NCT07317700 Conditions MF Locations West China Hospital Sichuan University — Chengdu, Sichuan, China Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) — Tianjin, Tianjin Municipality, China View Trial Details
Recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225 Conditions Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more Locations MPN Research Foundation — Chicago, Illinois, United States Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
Recruiting A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682 Conditions AML, Adnexal Diseases, CRPC, +20 more Locations Tianjin — Tianjin, Tianjin Municipality, China View Trial Details
Not Yet Recruiting Material Balance Study of [14C] Flonoltinib Maleate NCT07612306 Conditions MF Locations The First Affiliated Hospital of Soochow University — Suzhou, Jiangsu, China View Trial Details
